Advertisment

Appistry launches cloud-based service for genomics testing

author-image
Soma Tah
New Update

CHICAGO, USA: Appistry announced today the launch of Appistry CloudDx, a cloud-based service for ordering genomics tests. By collecting established laboratory-developed tests (LDTs) in a single, easy-to-access environment and streamlining the processes associated with delivering clinically relevant results to physicians,

Advertisment

Appistry CloudDx aims to place the genomically enhanced medicine now practiced at academic medical centers within the reach of community physicians and regional hospitals.

Appistry CloudDx provides a web-based dashboard for ordering established LDTs and tracking the status of individual orders across healthcare organizations. The cloud-based system orchestrates the flow of data and logistics among the network of service providers often needed to sequence samples, analyze sequencing data, and interpret the results for physicians.

This orchestration ensures that data and physical samples are transferred and securely managed in accordance with HIPAA and CLIA guidelines and that all processes essential for the rapid delivery of results to physicians occur consistently and efficiently.

Advertisment

Appistry CloudDx will include established LDTs from leading diagnostic test providers covering a range of diseases. Currently, the system includes panels and tests for cardiomyopathy, hearing loss, lung disease, and whole genome sequencing developed by Partners HealthCare Personalized Medicine. Additional tests and test partners will be announced in the coming weeks.

Additionally, the simplified workflow provided by Appistry CloudDx will enable hospitals to begin measuring and quantifying how genomics tests improve patient care and outcomes. Evidence of improved patient care and cost reductions due to genomics testing will be key in convincing insurance companies to cover the services.

"Appistry's approach is unique, because unlike many other test developers, we aren't attempting to dictate what science or workflow is best," said Kevin Haar, CEO of Appistry.

"Appistry CloudDx collects the best tests for a range of devastating, hard-to-treat diseases and scales the test developers' protocols to ensure accurate results and rapid turnaround. The result makes genomically enhanced medicine a viable option that can be easily implemented by physicians anywhere."